Medtronic (MDT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medtronic (MDT)

MDT 90.41

0.0%

Nov 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jack Hartmann who wrote (553)	10/29/2001 11:12:53 AM
From: Jack Hartmann	Read Replies (1) of 687

GS on MDT EPS (FY Apr): 2002E US$1.22, 2003E US$1.43 Recommended List Medtronic, Inc. MDT, $42.25 We continue to recommend purchase of Medtronic shares. Medtronic shares weakened on Friday following comments from a competing analyst that growth rate expectations for MiniMed may be too aggressive in light of the recent launch of Lantus, a long-acting insulin analog manufactured by Aventis. Although Lantus' s relatively peakless activity profile offers advantages over other basal insulins, we believe that the significantly improved glycemic control offered by programmable insulin pumps will drive continued 25-30% growth in MiniMed sales. As such, we would be buyers of the shares on weakness, particularly ahead of two-year BMP data to be presented at NASS on Thursday. Jack

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next